Teva to buy U.S. drug developer Auspex Pharma for $3.5 billion

(Reuters) - Israel's Teva Pharmaceutical Industries Ltd said it would buy U.S. drug developer Auspex Pharmaceuticals Inc for $3.5 billion to boost its portfolio of treatments for the central nervous system.

via Reuters: Health News Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://ift.tt/1xsyuPv